Figure 1.
Generation of skeletal muscle-specific smPit1−/−; smPit2−/− double knockout mice. (A) Mating scheme used to target ablation of Pit1 and Pit2 in postnatal skeletal muscle with the human skeletal actin (HSA) promoter Cre. (B) Genotyping PCR for Pit1fl, HSA-Cre, and Pit1wt. (C) Genotyping PCR for the recombinant Pit1delta3,4 and Pit2delta4 in various tissues of a smPit1−/−; smPit2−/− mouse at P10. For raw images see supplement. (D) Semi-quantitative qenomic PCR showed 20% reduced expression of the recombinant Pit1delta3,4 in heart when compared to quadriceps. For raw images see supplement. (E) Semi-quantitative RT-PCR showed reduced expression of Pit1 and Pit2 in quadriceps muscle of smPit1−/− and smPit2−/− mice at P80, respectively. Means ± SEM, n = 5–8, ***p = 0.0002, **p = 0.002, *p = 0.03 vs. WT.